Cellceutix Corporation – Product Pipeline Review

Global Markets Direct’s, ‘Cellceutix Corporation – Product Pipeline Review – 2016’, provides an overview of the Cellceutix Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Cellceutix Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Cellceutix Corporation

The report provides overview of Cellceutix Corporation including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Cellceutix Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Cellceutix Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Cellceutix Corporation’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Cellceutix Corporation

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Cellceutix Corporation’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Cellceutix Corporation Snapshot 6

Cellceutix Corporation Overview 6

Key Information 6

Key Facts 6

Cellceutix Corporation - Research and Development Overview 7

Key Therapeutic Areas 7

Cellceutix Corporation - Pipeline Review 14

Pipeline Products by Stage of Development 14

Pipeline Products - Monotherapy 15

Cellceutix Corporation - Pipeline Products Glance 16

Cellceutix Corporation - Clinical Stage Pipeline Products 16

Cellceutix Corporation - Early Stage Pipeline Products 18

Cellceutix Corporation - Drug Profiles 22

brilacidin tetrahydrochloride 22

KM-133 25

KM-3174 27

CC-1807 31

CTIX-1278 32

CTIX-1502 33

KM-277 34

KM-278 35

KM-362 36

KM-391 37

KM-732 39

PMX-0196 40

PMX-0243 41

PMX-10072 43

PMX-10098 44

PMX-1207 45

PMX-1241 46

PMX-1278 47

PMX-1405 48

PMX-1408 49

PMX-20005 51

PMX-207 52

PMX-225 53

PMX-231 55

PMX-255 57

PMX-30016 59

PMX-30024 60

PMX-496 61

PMX-504 62

PMX-519 63

PMX-611 65

PMX-647 66

PMX-835 67

Small Molecule to Disrupt Cell Membrane for Hidradenitis Suppurativa 68

PMX-100 69

PMX-1014 71

PMX-1045 72

PMX-1056 73

PMX-1057 74

PMX-1090 75

PMX-1091 76

PMX-1094 77

PMX-1099 78

PMX-1102 79

PMX-1142 80

PMX-1363 81

PMX-1424 82

PMX-1442 83

PMX-1445 84

PMX-1467 85

PMX-1488 86

PMX-1533 87

PMX-1547 88

PMX-1555 89

PMX-1560 90

PMX-1570 91

PMX-1572 92

PMX-1573 93

PMX-1576 94

PMX-1591 95

PMX-1625 96

PMX-183 97

PMX-223 98

PMX-229 99

PMX-247 100

PMX-520 101

PMX-633 102

PMX-668 103

PMX-693 104

PMX-70004 105

PMX-728 107

PMX-741 108

PMX-843 109

PMX-868 110

Cellceutix Corporation - Pipeline Analysis 111

Cellceutix Corporation - Pipeline Products by Target 111

Cellceutix Corporation - Pipeline Products by Route of Administration 112

Cellceutix Corporation - Pipeline Products by Molecule Type 113

Cellceutix Corporation - Pipeline Products by Mechanism of Action 114

Cellceutix Corporation - Recent Pipeline Updates 115

Cellceutix Corporation - Dormant Projects 149

Cellceutix Corporation - Locations And Subsidiaries 150

Head Office 150

Appendix 151

Methodology 151

Coverage 151

Secondary Research 151

Primary Research 151

Expert Panel Validation 151

Contact Us 151

Disclaimer 152

List of Tables

List of Tables

Cellceutix Corporation, Key Information 11

Cellceutix Corporation, Key Facts 11

Cellceutix Corporation – Pipeline by Indication, 2016 13

Cellceutix Corporation – Pipeline by Stage of Development, 2016 19

Cellceutix Corporation – Monotherapy Products in Pipeline, 2016 20

Cellceutix Corporation – Phase II, 2016 21

Cellceutix Corporation – Phase I, 2016 22

Cellceutix Corporation – Preclinical, 2016 23

Cellceutix Corporation – Discovery, 2016 25

Cellceutix Corporation – Pipeline by Target, 2016 116

Cellceutix Corporation – Pipeline by Route of Administration, 2016 117

Cellceutix Corporation – Pipeline by Molecule Type, 2016 118

Cellceutix Corporation – Pipeline Products by Mechanism of Action, 2016 119

Cellceutix Corporation – Recent Pipeline Updates, 2016 120

Cellceutix Corporation – Dormant Developmental Projects,2016 154

List of Figures

List of Figures

Cellceutix Corporation – Pipeline by Top 10 Indication, 2016 13

Cellceutix Corporation – Pipeline by Stage of Development, 2016 19

Cellceutix Corporation – Monotherapy Products in Pipeline, 2016 20

Cellceutix Corporation – Pipeline by Target, 2016 116

Cellceutix Corporation – Pipeline by Route of Administration, 2016 117

Cellceutix Corporation – Pipeline by Molecule Type, 2016 118

Cellceutix Corporation – Pipeline Products by Mechanism of Action, 2016 119

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports